ArticleInternational journal of surgery case reports2026
Squamous cell carcinoma of the ampulla of Vater: a rare case report and review of the literature.
Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Primary squamous cell carcinoma (SCC) of the ampulla of Vater is an exceptionally rare malignancy, with only a limited number of cases reported in the literature. Its pathogenesis, biological behavior, and optimal management remain poorly defined. Case presentation: We report the case of a 68-year-old man presenting with several weeks of atypical abdominal discomfort and cholestatic liver enzyme abnormalities. Upper gastrointestinal endoscopy revealed an ulcerated ampullary lesion, and biopsy confirmed moderately to poorly differentiated SCC. Cross-sectional imaging excluded metastatic disease. The patient underwent pylorus-preserving pancreaticoduodenectomy. Histopathological analysis confirmed primary SCC (pT2N0M0) with negative margins (R0 resection). Adjuvant chemotherapy with cisplatin and 5-fluorouracil was initiated 6 weeks postoperatively, with a planned duration of 6 months. The patient remains disease-free at 6-month follow-up. Discussion: Ampullary SCC is rare but not unique, with several cases reported. Surgical resection remains the cornerstone of treatment. Adjuvant therapy is extrapolated from other SCCs due to a lack of evidence. Prognosis appears variable, with better outcomes in node-negative disease. Conclusion: This case highlights the importance of accurate histopathological diagnosis and reinforces the role of radical surgical resection. Further case accumulation is required to define optimal management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.